期刊文献+

盐酸头孢他美钠注射剂在大鼠体内的排泄研究

Excretion study of cefetamet hydrochloride sodium injection in rats
下载PDF
导出
摘要 目的建立反相高效液相色谱法测定尿液、粪便和胆汁样品中的头孢他美含量,研究头孢他美在大鼠体内的排泄情况。方法 SD大鼠单剂量静注盐酸头孢他美钠50 mg/kg后,收集粪、尿、胆汁,采用HPLC法测定药物浓度,色谱柱为Ultimate C18(5μm,150 mm×4.6 mm),流动相为甲醇-10 mmol/L KH2PO4(含质量分数0.05%甲酸),流速为1.0 mL/min,紫外检测波长为272 nm和262 nm,柱温为30℃,再分别计算累积排泄率。结果单剂量静注头孢他美后,48 h内原形从尿及粪便中排泄量为(5 403.588±1 052.684)μg、(820.351±296.056)μg,累积排泄率为(54.036±10.527)%、(8.204±2.961)%,24 h内原形从胆汁中排泄量为(3 344.234±227.819)μg,累积排泄率为(33.442±2.278)%。结论头孢他美主要以原形从尿液、粪便和胆汁中排出体外。 Objective A sensitive and reliable reversed phase high-performance liquid chromatography method has been developed and validated for determination of cefetamet in urine, feces and bile, and study the excretion of cefetamet after intravenous administration. Methods Urine, feces and bile were collected after a single intravenous dose of 50 mg/kg to rats. The validated HPLC method was used to determine the concentration of cefetamet in urine,feces and bile. The Ultimate Cls (5 ~m, 150 mm x4.6 mm)was selected as separation column,methanol and 10 mmol/L monopotassium phosphate containing 0. 05% formic was used for mobile phase at a flow rate of 1.0 mL/min,with the detection wavelength of 272 nm and 262 nm, and calculating the accumulation excretion amount. Results The accumulation excretion amount of cefetamet in urine and feces within 48 h were (5 403. 588 ± 1 052. 684) μg and (820.351 ± 296. 056) μg respectively, and (3 344. 234± 227. 819) μg in bile within 24 h. The excretion rate in urine,feces and bile were (54. 036 ± 10. 527)% , (8. 204±2. 961 )% and (33. 442 ± 2. 278 )%. Conclusion The unchanged compound is mainly excreted in urine, feces and bile.
出处 《广东药学院学报》 CAS 2013年第5期483-487,共5页 Academic Journal of Guangdong College of Pharmacy
基金 科技部"重大新药创制"科技重大专项(2009ZX09103-123 2012ZX09102101-005)
关键词 头孢他美钠 大鼠 排泄量 高效液相色谱法 cefetamet sodium rats excretion HPLC
  • 相关文献

参考文献11

二级参考文献74

  • 1徐积恩.头孢他美酯的药理和临床应用进展[J].国外医药(抗生素分册),1994,15(6):431-434. 被引量:2
  • 2戴自英.实用抗菌药物学[M].上海:上海科学技术出版社,1994.189.
  • 3徐积恩.-[J].国外医药:抗生素分册,1994,15(6):11-11.
  • 4小川芳毅.-[J].国外医药:抗生素分册,1994,15(4):7-7.
  • 5朱宁.-[J].中国抗生素杂志,1998,23(6):12-12.
  • 61,Bryson HM and Brogden RN.Cefetamet pivoxil,a review of its antibacterial activity,pharmacokinetic properties and therapeutic use.Drugs,1993;45:589~621.
  • 72,Wyss R and Bucheli F.Determination of cefetamet and its orally active ester,cefetamet pivoxyl,in biological fluids by high-performance liquid chromatography.J Chromatogr,1988;430:81~92.
  • 83,Tam YK,Kneer J,Dubach UC,Stoeckel K.Pharmacokinetics of cefetamet pivoxil(Ro 15-8075) with ascending oral doses in normal healthy volunteers.Antimicrob Ag Chemother,1989;33:957~959.
  • 94,Koup JR,Dubach UC,Brandt R,Wyss R,Stoeckel K.Pharmacokinetics of cefetamet(Ro-8074) and cefetamet pivoxil(Ro 15-8075) after intravenous and oral doses in humans.Antimicrob Ag Chemother,1988;32:573~579.
  • 105,Blouin RA,Kneer J,Stoeckel K.Pharmacokinetics of intravenous cefetamet(Ro 15-8074) and oral cefetamet pivoxil(Ro 15-8075) in young and elderly subjects.Antimicrob Ag Chemother,1989;33:291~296.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部